Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 38 USD 2.1%
Market Cap: 332.5m USD
Have any thoughts about
Sanara Medtech Inc?
Write Note

Intrinsic Value

SMTI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one SMTI stock under the Base Case scenario is 38.91 USD. Compared to the current market price of 38 USD, Sanara Medtech Inc is Undervalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SMTI Intrinsic Value
38.91 USD
Undervaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Sanara Medtech Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SMTI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SMTI?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Sanara Medtech Inc

Provide an overview of the primary business activities
of Sanara Medtech Inc.

What unique competitive advantages
does Sanara Medtech Inc hold over its rivals?

What risks and challenges
does Sanara Medtech Inc face in the near future?

Summarize the latest earnings call
of Sanara Medtech Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sanara Medtech Inc.

Provide P/S
for Sanara Medtech Inc.

Provide P/E
for Sanara Medtech Inc.

Provide P/OCF
for Sanara Medtech Inc.

Provide P/FCFE
for Sanara Medtech Inc.

Provide P/B
for Sanara Medtech Inc.

Provide EV/S
for Sanara Medtech Inc.

Provide EV/GP
for Sanara Medtech Inc.

Provide EV/EBITDA
for Sanara Medtech Inc.

Provide EV/EBIT
for Sanara Medtech Inc.

Provide EV/OCF
for Sanara Medtech Inc.

Provide EV/FCFF
for Sanara Medtech Inc.

Provide EV/IC
for Sanara Medtech Inc.

Show me price targets
for Sanara Medtech Inc made by professional analysts.

What are the Revenue projections
for Sanara Medtech Inc?

How accurate were the past Revenue estimates
for Sanara Medtech Inc?

What are the Net Income projections
for Sanara Medtech Inc?

How accurate were the past Net Income estimates
for Sanara Medtech Inc?

What are the EPS projections
for Sanara Medtech Inc?

How accurate were the past EPS estimates
for Sanara Medtech Inc?

What are the EBIT projections
for Sanara Medtech Inc?

How accurate were the past EBIT estimates
for Sanara Medtech Inc?

Compare the revenue forecasts
for Sanara Medtech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sanara Medtech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sanara Medtech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sanara Medtech Inc compared to its peers.

Compare the P/E ratios
of Sanara Medtech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Sanara Medtech Inc with its peers.

Analyze the financial leverage
of Sanara Medtech Inc compared to its main competitors.

Show all profitability ratios
for Sanara Medtech Inc.

Provide ROE
for Sanara Medtech Inc.

Provide ROA
for Sanara Medtech Inc.

Provide ROIC
for Sanara Medtech Inc.

Provide ROCE
for Sanara Medtech Inc.

Provide Gross Margin
for Sanara Medtech Inc.

Provide Operating Margin
for Sanara Medtech Inc.

Provide Net Margin
for Sanara Medtech Inc.

Provide FCF Margin
for Sanara Medtech Inc.

Show all solvency ratios
for Sanara Medtech Inc.

Provide D/E Ratio
for Sanara Medtech Inc.

Provide D/A Ratio
for Sanara Medtech Inc.

Provide Interest Coverage Ratio
for Sanara Medtech Inc.

Provide Altman Z-Score Ratio
for Sanara Medtech Inc.

Provide Quick Ratio
for Sanara Medtech Inc.

Provide Current Ratio
for Sanara Medtech Inc.

Provide Cash Ratio
for Sanara Medtech Inc.

What is the historical Revenue growth
over the last 5 years for Sanara Medtech Inc?

What is the historical Net Income growth
over the last 5 years for Sanara Medtech Inc?

What is the current Free Cash Flow
of Sanara Medtech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sanara Medtech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sanara Medtech Inc

Current Assets 20.8m
Cash & Short-Term Investments 6.2m
Receivables 10.6m
Other Current Assets 4.1m
Non-Current Assets 52.6m
Long-Term Investments 3.1m
PP&E 2.9m
Intangibles 46.6m
Other Non-Current Assets 10
Current Liabilities 11.6m
Accounts Payable 896k
Accrued Liabilities 9.6m
Other Current Liabilities 1.1m
Non-Current Liabilities 20.1m
Long-Term Debt 14.4m
Other Non-Current Liabilities 5.7m
Efficiency

Earnings Waterfall
Sanara Medtech Inc

Revenue
72.4m USD
Cost of Revenue
-7.4m USD
Gross Profit
65m USD
Operating Expenses
-70.5m USD
Operating Income
-5.6m USD
Other Expenses
-1m USD
Net Income
-6.6m USD

Free Cash Flow Analysis
Sanara Medtech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SMTI Profitability Score
Profitability Due Diligence

Sanara Medtech Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
ROE is Increasing
33/100
Profitability
Score

Sanara Medtech Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

SMTI Solvency Score
Solvency Due Diligence

Sanara Medtech Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

Sanara Medtech Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SMTI Price Targets Summary
Sanara Medtech Inc

Wall Street analysts forecast SMTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMTI is 44.88 USD with a low forecast of 44.44 USD and a high forecast of 46.2 USD.

Lowest
Price Target
44.44 USD
17% Upside
Average
Price Target
44.88 USD
18% Upside
Highest
Price Target
46.2 USD
22% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SMTI?

Click here to dive deeper.

Dividends

Sanara Medtech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SMTI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Sanara Medtech Inc Logo
Sanara Medtech Inc

Country

United States of America

Industry

Health Care

Market Cap

325.6m USD

Dividend Yield

0%

Description

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

Contact

TEXAS
Fort Worth
1200 Summit Ave Ste 414
+18175292300.0
sanaramedtech.com

IPO

1994-04-07

Employees

63

Officers

Executive Chairman & CEO
Mr. Ronald T. Nixon
CFO & Corporate Secretary
Mr. Michael D. McNeil
Chief Operating Officer
Mr. Jacob A. Waldrop
Chief Compliance Officer
Mr. Bill Fitzgerald
Vice President of Marketing
Ms. Tricia Matteson
Chief Corporate Development & Strategy Officer
Mr. Tyler Palmer
Show More
President of Telehealth Services
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D.
President of Research & Development
Dr. Rebecca Erin Mcmahon
President of Commercial
Mr. Seth Yon
Vice President of Corporate Operations
Mr. Callon Nichols
Show Less

See Also

Discover More
What is the Intrinsic Value of one SMTI stock?

The intrinsic value of one SMTI stock under the Base Case scenario is 38.91 USD.

Is SMTI stock undervalued or overvalued?

Compared to the current market price of 38 USD, Sanara Medtech Inc is Undervalued by 2%.

Back to Top